Mark Hamann to Alzheimer Disease
This is a "connection" page, showing publications Mark Hamann has written about Alzheimer Disease.
Connection Strength
0.476
-
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease. J Nat Prod. 2007 Sep; 70(9):1397-405.
Score: 0.205
-
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod. 2006 Jul; 69(7):1034-40.
Score: 0.190
-
Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-? aggregation inhibitors. Mar Drugs. 2014 Apr 04; 12(4):2114-31.
Score: 0.081